首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1080223篇
  免费   125828篇
  国内免费   1081篇
  2016年   12487篇
  2015年   18569篇
  2014年   21667篇
  2013年   30052篇
  2012年   34437篇
  2011年   34803篇
  2010年   23522篇
  2009年   21936篇
  2008年   31486篇
  2007年   32386篇
  2006年   30482篇
  2005年   29162篇
  2004年   29150篇
  2003年   27760篇
  2002年   27074篇
  2001年   44644篇
  2000年   44946篇
  1999年   36288篇
  1998年   14257篇
  1997年   14745篇
  1996年   14109篇
  1995年   13371篇
  1994年   13056篇
  1993年   12900篇
  1992年   30877篇
  1991年   30130篇
  1990年   29786篇
  1989年   28887篇
  1988年   26676篇
  1987年   25921篇
  1986年   24051篇
  1985年   24171篇
  1984年   20121篇
  1983年   17603篇
  1982年   13901篇
  1981年   12503篇
  1980年   11810篇
  1979年   19362篇
  1978年   15723篇
  1977年   14232篇
  1976年   13418篇
  1975年   14817篇
  1974年   16082篇
  1973年   15768篇
  1972年   14182篇
  1971年   13163篇
  1970年   11233篇
  1969年   10746篇
  1968年   9670篇
  1967年   8753篇
排序方式: 共有10000条查询结果,搜索用时 296 毫秒
301.
302.
BHK cells either untreated or infected with Semliki Forest virus have been fractionated on sucrose density gradients. Virus infection caused an increase in density of a membrane fraction enriched in sphingomyelin (SM), cholesterol, SM synthase and sialyltransferase activity. This increase in density was related to incorporation of viral proteins into this fraction, which is likely to contain trans-Golgi network (TGN) membranes. In contrast, glucosylceramide synthase and galactosyltransferase activities (markers for cis/medial and trans-Golgi respectively) underwent no density shift and alkaline phosphodiesterase, a plasma membrane marker, was only slightly density-shifted in infected cells. When cells were incubated with NBD-ceramide to enable them to synthesise NBD-SM and then washed with albumin to remove surface label, fluorescence in untreated cells was concentrated in a single juxtanuclear spot but in infected cells this region of bright fluorescence was larger and extended around the nucleus. After fractionation of these cells, NBD-SM (but only a small proportion of the NBD-ceramide) was found to be shifted into the higher density fraction in infected cells. This work provides further evidence that SM synthase is not mainly localised in the early Golgi cisternae as previously thought, but is associated more with a cholesterol-rich compartment which could be the TGN.  相似文献   
303.
In this paper we quantify and characterize the expression of recombinant beta-lactoglobulin (rBLG) in prokaryote and eukaryote cells. In Escherichia coli we used the pET26 vector, which permits the secretion of rBLG in periplasm. We studied the expression of rBLG in COS-7 cells and in vivo in mouse tibialis muscle. The expression of rBLG was measured by two immunoassays specific, respectively, for BLG in its native and denatured conformation. We observed that rBLG was essentially expressed in a denatured form in E. coli even in the periplasm, whereas rBLG in eukaryote cells was found in its native conformation.  相似文献   
304.
A rational attempt to prepare FmocHis(piTrt)OH regiospecifically gave in fact the well-known tau-trityl isomer, and experiments with model systems indicate that the prospects for access to pi-trityl histidine derivatives, which would be of great value for the racemization-free synthesis of histidine-containing peptides, are poor.  相似文献   
305.
306.
307.
The recent identification of VKORC1 has made important contributions to our understanding of the vitamin K cycle. The VKORC1 enzyme was shown to be the molecular target of coumarin drugs. Mutations and polymorphisms in coding and noncoding regions of the VKORC1 gene have been shown to cause both a partial to total coumarin resistance and coumarin sensitivity. Availability of molecular diagnostics (VKORC1, CYP2C9) and drug monitoring by HCPLC (determination of coumarin, vitamin K, and vitamin K epoxide levels) is helpful for detecting hereditary and acquired factors influencing coumarin therapy. In the future, these tools may be instrumental in designing individualized oral anticoagulation therapy regimens.  相似文献   
308.
309.
310.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号